Login / Signup

Repeatability of methylation measures using a QIAseq targeted methyl panel and comparison with the Illumina HumanMethylation450 assay.

Chenglong YuPierre-Antoine DuguéJames G DowtyFleur HammetJiHoon E JooEe Ming WongMahnaz HosseinpourGraham G GilesJohn L HopperTu Nguyen-DumontRobert J MacInnisMelissa C Southey
Published in: BMC research notes (2021)
The repeatability of QIAseq-methylation measures was assessed at 40 CpGs, using the Intraclass Correlation Coefficient (ICC). The mean ICCs and 95% confidence intervals (CI) were 0.72 (0.62-0.81), 0.59 (0.47-0.71) and 0.80 (0.73-0.88) for WB, FFPE and both sample types combined, respectively. For technical replicates measured using QIAseq and HM450K, the mean ICCs (95% CI) were 0.53 (0.39-0.68), 0.43 (0.31-0.56) and 0.70 (0.59-0.80), respectively. Bland-Altman plots indicated good agreement between QIAseq and HM450K measurements. These results demonstrate that the QIAseq targeted methyl panel produces reliable and reproducible methylation measurements across the 40 CpGs that were examined.
Keyphrases
  • genome wide
  • dna methylation
  • cancer therapy
  • high throughput
  • magnetic resonance imaging
  • computed tomography
  • single cell